Cas no 21249-35-4 (Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-)
![Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]- structure](https://ossimg.kuujia.com/scimg/21500/21249-35-4x500.png)
21249-35-4 structure
Product Name:Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
CAS No:21249-35-4
MF:C32H54N2O2
MW:498.783369541168
CID:287750
PubChem ID:179356
Update Time:2025-04-19
Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]- Chemical and Physical Properties
Names and Identifiers
-
- Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]docosanamide
- DTXSID90175498
- 21249-35-4
- SCHEMBL1746356
- N-behenoyl-5-hydroxytryptamide
- N-Behenoyl-5-hydroxytryptamine
- Docosanamide, N-(2-(5-hydroxyindol-3-yl)ethyl)-
- XNISEOLHGQOJHH-UHFFFAOYSA-N
- Behemic acid 5-hydroxytryptamide
- Scorodocarpine A
- N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]docosanamide #
-
- Inchi： 1S/C32H54N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(36)33-25-24-28-27-34-31-23-22-29(35)26-30(28)31/h22-23,26-27,34-35H,2-21,24-25H2,1H3,(H,33,36)
- InChI Key： XNISEOLHGQOJHH-UHFFFAOYSA-N
- SMILES： O=C(CCCCCCCCCCCCCCCCCCCCC)NCCC1=CNC2C=CC(=CC1=2)O
Computed Properties
- Exact Mass: 498.41882
- Monoisotopic Mass: 498.41852897g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 36
- Rotatable Bond Count: 23
- Complexity: 526
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 11
- Topological Polar Surface Area: 65.1?2
Experimental Properties
- PSA: 65.12
Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]- Related Literature
-
Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
21249-35-4 (Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-) Related Products
- 1210-83-9(N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
Recommended suppliers
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
煙臺朗裕新材料科技有限公司
Gold Member
Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Reagent
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
